Skip to content

Fibromyalgia Integrative Training for Teens

Fibromyalgia Integrative Training for Teens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01981096
Acronym
FIT Teens
Enrollment
40
Registered
2013-11-11
Start date
2013-11-30
Completion date
2016-12-31
Last updated
2022-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Fibromyalgia

Keywords

juvenile fibromyalgia, pain in children, musculoskeletal pain, cognitive behavioral therapy, coping skills training

Brief summary

The purpose of this pilot randomized trial is to determine whether the fibromyalgia integrative training (FIT Teens) intervention is superior to cognitive-behavioral therapy (CBT) alone in reducing pain among adolescents with juvenile fibromyalgia (JFM). Hypothesis 1: Patients in the FIT Teens group will show significantly greater reduction in pain intensity than the CBT group at final study assessment (i.e., 3-month follow up). Hypothesis 2: Patients in both the FIT Teens and CBT groups will show significant reductions in functional disability and depressive symptoms at final study assessment (i.e., 3-month follow up).

Detailed description

CBT has been found to have beneficial effects on improving coping among adolescents with JFM and increasing patients' ability to engage in daily activities. The purpose of this study is to evaluate whether CBT can be enhanced with specialized neuromuscular training, in the new fibromyalgia integrative training (FIT Teens) intervention, to produce stronger pain reduction than CBT alone. Neuromuscular training originates from the field of pediatric sports medicine and has been successfully used for injury prevention but has never before been utilized for pain management in JFM. This type of training emphasizes education and proper training in fundamental movement skills prior to the initiation of more vigorous physical activity and exercise. It is expected that the neuromuscular training integrated with established CBT techniques will enhance patients' ability to engage in exercise and to achieve better JFM pain control. Adolescents with JFM will be randomly assigned to receive either the 8-week FIT Teens intervention or an 8-week CBT program with assessments at baseline, post-treatment and 3-month follow-up.

Interventions

BEHAVIORALFibromyalgia integrative training

Combined intervention with neuromuscular exercise training and cognitive behavioral therapy

BEHAVIORALCognitive Behavioral Therapy

Therapy focused on training in behavioral pain coping skills

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Males and females ages 12-18 * Juvenile fibromyalgia (JFM) diagnosed by a pediatric rheumatologist or pain physician using 2010 American College of Rheumatology (ACR) criteria and confirmation with a tender point exam of ≥ 11 of 18 tender points upon palpation * Functional Disability Score ≥13 indicating at least moderate disability * Average pain intensity in the past week ≥ 4 on a 0-10 cm Visual Analog Scale

Exclusion criteria

* Comorbid rheumatic disease (e.g., juvenile arthritis, systemic lupus erythematous) * untreated major psychiatric diagnoses (e.g., major depression, bipolar disorder, psychoses) * documented developmental delay * any medical condition determined by their physician to be a contraindication for participation * on stable medications for 4 weeks prior to enrollment * currently in CBT or structured physical therapy program

Design outcomes

Primary

MeasureTime frameDescription
Average Pain IntensityBaseline, post-treatment and 3-month follow-upAverage pain intensity in the past week marked on a paper-pencil Visual Analog Scale (Min = 0 {no pain} to Max = 10 {pain as bad as it can be}). Lower scores mean better outcomes.

Secondary

MeasureTime frameDescription
Functional DisabilityBaseline, post-treatment and 3-month follow-upValidated 15-item patient-report measure of difficulties in physical, social and recreational activities in the past 2 weeks (score Min = 0, Max = 60; Lower score means less disability/better outcome)
Depressive SymptomsBaseline, Post-treatment, 3-month follow-upChildren's Depression Inventory: a 27-item validated patient-report measure of depressive symptoms in the past 2 weeks (scores 0 = no depressive symptoms to 54 = most severe symptoms; lower score means less depression/better outcomes)

Countries

United States

Participant flow

Participants by arm

ArmCount
Fibromyalgia Integrative Training
8 week (16 sessions) combined intervention with cognitive-behavioral therapy and neuromuscular training Fibromyalgia integrative training: Combined intervention with neuromuscular exercise training and cognitive behavioral therapy
20
Cognitive Behavioral Therapy
8 week (16 session) cognitive-behavioral therapy treatment. Cognitive Behavioral Therapy: Therapy focused on training in behavioral pain coping skills
20
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up20
Overall StudyParent illness10
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicFibromyalgia Integrative TrainingTotalCognitive Behavioral Therapy
Age, Continuous15.15 years
STANDARD_DEVIATION 1.69
15.33 years
STANDARD_DEVIATION 1.53
15.50 years
STANDARD_DEVIATION 1.36
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants40 Participants20 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
19 Participants37 Participants18 Participants
Region of Enrollment
United States
20 Participants40 Participants20 Participants
Sex: Female, Male
Female
17 Participants36 Participants19 Participants
Sex: Female, Male
Male
3 Participants4 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
7 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Average Pain Intensity

Average pain intensity in the past week marked on a paper-pencil Visual Analog Scale (Min = 0 {no pain} to Max = 10 {pain as bad as it can be}). Lower scores mean better outcomes.

Time frame: Baseline, post-treatment and 3-month follow-up

Population: 20 participants randomized in each group. 3 dropped out of study before post-treatment and follow-up assessments.

ArmMeasureGroupValue (MEAN)Dispersion
Fibromyalgia Integrative TrainingAverage Pain IntensityBaseline6.26 units on a scaleStandard Deviation 2.06
Fibromyalgia Integrative TrainingAverage Pain IntensityPost-treatment4.69 units on a scaleStandard Deviation 2.13
Fibromyalgia Integrative TrainingAverage Pain IntensityPrimary endpoint (3-month f/u)4.62 units on a scaleStandard Deviation 1.9
Cognitive Behavioral TherapyAverage Pain IntensityBaseline6.41 units on a scaleStandard Deviation 1.59
Cognitive Behavioral TherapyAverage Pain IntensityPost-treatment6.38 units on a scaleStandard Deviation 2.31
Cognitive Behavioral TherapyAverage Pain IntensityPrimary endpoint (3-month f/u)6.55 units on a scaleStandard Deviation 1.22
Comparison: This analysis represents the between group comparisons (i.e., FIT Teens vs. CBT) from baseline assessment to the 3-month follow-up, the primary endpoint of the trial.p-value: 0.011ANCOVA
Secondary

Depressive Symptoms

Children's Depression Inventory: a 27-item validated patient-report measure of depressive symptoms in the past 2 weeks (scores 0 = no depressive symptoms to 54 = most severe symptoms; lower score means less depression/better outcomes)

Time frame: Baseline, Post-treatment, 3-month follow-up

Population: 20 participants randomized to each group. 4 participants dropped out prior to post-treatment and follow-up assessments.

ArmMeasureGroupValue (MEAN)Dispersion
Fibromyalgia Integrative TrainingDepressive SymptomsBaseline15.8 score on a scaleStandard Deviation 6.85
Fibromyalgia Integrative TrainingDepressive SymptomsPost-Treatment11.71 score on a scaleStandard Deviation 5.7
Fibromyalgia Integrative TrainingDepressive Symptoms3-month Follow-up11.35 score on a scaleStandard Deviation 6.52
Cognitive Behavioral TherapyDepressive SymptomsBaseline14.05 score on a scaleStandard Deviation 6.18
Cognitive Behavioral TherapyDepressive SymptomsPost-Treatment13.79 score on a scaleStandard Deviation 7.56
Cognitive Behavioral TherapyDepressive Symptoms3-month Follow-up12.95 score on a scaleStandard Deviation 7.55
Secondary

Functional Disability

Validated 15-item patient-report measure of difficulties in physical, social and recreational activities in the past 2 weeks (score Min = 0, Max = 60; Lower score means less disability/better outcome)

Time frame: Baseline, post-treatment and 3-month follow-up

Population: 20 participants randomized to each group. 4 participants dropped out prior to post-treatment and follow-up assessments.

ArmMeasureGroupValue (MEAN)Dispersion
Fibromyalgia Integrative TrainingFunctional DisabilityBaseline26.70 units on a scaleStandard Deviation 7.27
Fibromyalgia Integrative TrainingFunctional DisabilityPost-treatment18.71 units on a scaleStandard Deviation 4.61
Fibromyalgia Integrative TrainingFunctional DisabilityPrimary endpoint (3 month f/u)19.76 units on a scaleStandard Deviation 5.55
Cognitive Behavioral TherapyFunctional DisabilityBaseline24.45 units on a scaleStandard Deviation 8.29
Cognitive Behavioral TherapyFunctional DisabilityPost-treatment23.95 units on a scaleStandard Deviation 11.04
Cognitive Behavioral TherapyFunctional DisabilityPrimary endpoint (3 month f/u)22.68 units on a scaleStandard Deviation 9.01
Comparison: This analysis represents the between group comparisons (i.e., FIT Teens vs. CBT) from baseline assessment to the 3-month follow-up, the primary endpoint of the trial.p-value: 0.055ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026